Overview
Fumihiro Fujiki practices in Osaka, Japan. Fujiki is rated as an Advanced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Their top areas of expertise are Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), and Leukemia.
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Wilms TumorFujiki isDistinguished. Learn about Wilms Tumor.
- Advanced
- WT1-Related Wilms Tumor Syndromes
- Experienced
- Acute Myeloid Leukemia (AML)Fujiki isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaFujiki isExperienced. Learn about Leukemia.
- Multiple MyelomaFujiki isExperienced. Learn about Multiple Myeloma.
- Renal Cell Carcinoma (RCC)Fujiki isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Thymic Epithelial TumorFujiki isExperienced. Learn about Thymic Epithelial Tumor.